HEADER HYDROLASE/HYDROLASE INHIBITOR 07-DEC-14 4X68 TITLE CRYSTAL STRUCTURE OF OP0595 COMPLEXED WITH AMPC COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-LACTAMASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 32-387; COMPND 5 SYNONYM: CEPHALOSPORINASE; COMPND 6 EC: 3.5.2.6; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS AERUGINOSA; SOURCE 3 ORGANISM_TAXID: 208964; SOURCE 4 STRAIN: ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228; SOURCE 5 GENE: AMPC, PA4110; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28B KEYWDS HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.YAMADA,T.WATANABE REVDAT 5 06-NOV-24 4X68 1 REMARK REVDAT 4 08-NOV-23 4X68 1 LINK REVDAT 3 05-FEB-20 4X68 1 REMARK REVDAT 2 14-OCT-15 4X68 1 JRNL REVDAT 1 01-JUL-15 4X68 0 JRNL AUTH A.MORINAKA,Y.TSUTSUMI,M.YAMADA,K.SUZUKI,T.WATANABE,T.ABE, JRNL AUTH 2 T.FURUUCHI,S.INAMURA,Y.SAKAMAKI,N.MITSUHASHI,T.IDA, JRNL AUTH 3 D.M.LIVERMORE JRNL TITL OP0595, A NEW DIAZABICYCLOOCTANE: MODE OF ACTION AS A SERINE JRNL TITL 2 BETA-LACTAMASE INHIBITOR, ANTIBIOTIC AND BETA-LACTAM JRNL TITL 3 'ENHANCER' JRNL REF J.ANTIMICROB.CHEMOTHER. V. 70 2779 2015 JRNL REFN ESSN 1460-2091 JRNL PMID 26089439 JRNL DOI 10.1093/JAC/DKV166 REMARK 2 REMARK 2 RESOLUTION. 1.68 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REFMAC_5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.68 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 67948 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 3308 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5546 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 44 REMARK 3 SOLVENT ATOMS : 242 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.89 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.09000 REMARK 3 B22 (A**2) : -1.53000 REMARK 3 B33 (A**2) : 0.43000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.24000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.137 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.128 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.094 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.801 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 4X68 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 09-DEC-14. REMARK 100 THE DEPOSITION ID IS D_1000205006. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-JUL-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL41XU REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : ROTATED-INCLINED DOUBLE-CRYSTAL REMARK 200 MONOCHROMATOR , SI (111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX225HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 67982 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.680 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.07400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.68 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.56400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 2WZX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.95 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 2000 MONOMETHYLETHER, NICL2, PH REMARK 280 8.5, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 27.39050 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICAL UNIT IS THE SAME AS ASYM. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2070 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27100 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 249 14.48 -160.03 REMARK 500 GLU A 269 -7.88 -53.89 REMARK 500 ASN A 368 39.30 -96.94 REMARK 500 TYR B 249 17.25 -158.04 REMARK 500 ASN B 368 39.72 -98.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NI A 403 NI REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 149 OD2 REMARK 620 2 HIS B 267 NE2 77.2 REMARK 620 3 ASP B 360 OD1 67.0 65.3 REMARK 620 N 1 2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OP0 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NI A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NI A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide OP0 B 401 and SER B REMARK 800 90 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4X69 RELATED DB: PDB DBREF 4X68 A 32 387 UNP P24735 AMPC_PSEAE 32 387 DBREF 4X68 B 32 387 UNP P24735 AMPC_PSEAE 32 387 SEQADV 4X68 MET A 31 UNP P24735 INITIATING METHIONINE SEQADV 4X68 MET B 31 UNP P24735 INITIATING METHIONINE SEQRES 1 A 357 MET ASP ARG LEU LYS ALA LEU VAL ASP ALA ALA VAL GLN SEQRES 2 A 357 PRO VAL MET LYS ALA ASN ASP ILE PRO GLY LEU ALA VAL SEQRES 3 A 357 ALA ILE SER LEU LYS GLY GLU PRO HIS TYR PHE SER TYR SEQRES 4 A 357 GLY LEU ALA SER LYS GLU ASP GLY ARG ARG VAL THR PRO SEQRES 5 A 357 GLU THR LEU PHE GLU ILE GLY SER VAL SER LYS THR PHE SEQRES 6 A 357 THR ALA THR LEU ALA GLY TYR ALA LEU THR GLN ASP LYS SEQRES 7 A 357 MET ARG LEU ASP ASP ARG ALA SER GLN HIS TRP PRO ALA SEQRES 8 A 357 LEU GLN GLY SER ARG PHE ASP GLY ILE SER LEU LEU ASP SEQRES 9 A 357 LEU ALA THR TYR THR ALA GLY GLY LEU PRO LEU GLN PHE SEQRES 10 A 357 PRO ASP SER VAL GLN LYS ASP GLN ALA GLN ILE ARG ASP SEQRES 11 A 357 TYR TYR ARG GLN TRP GLN PRO THR TYR ALA PRO GLY SER SEQRES 12 A 357 GLN ARG LEU TYR SER ASN PRO SER ILE GLY LEU PHE GLY SEQRES 13 A 357 TYR LEU ALA ALA ARG SER LEU GLY GLN PRO PHE GLU ARG SEQRES 14 A 357 LEU MET GLU GLN GLN VAL PHE PRO ALA LEU GLY LEU GLU SEQRES 15 A 357 GLN THR HIS LEU ASP VAL PRO GLU ALA ALA LEU ALA GLN SEQRES 16 A 357 TYR ALA GLN GLY TYR GLY LYS ASP ASP ARG PRO LEU ARG SEQRES 17 A 357 VAL GLY PRO GLY PRO LEU ASP ALA GLU GLY TYR GLY VAL SEQRES 18 A 357 LYS THR SER ALA ALA ASP LEU LEU ARG PHE VAL ASP ALA SEQRES 19 A 357 ASN LEU HIS PRO GLU ARG LEU ASP ARG PRO TRP ALA GLN SEQRES 20 A 357 ALA LEU ASP ALA THR HIS ARG GLY TYR TYR LYS VAL GLY SEQRES 21 A 357 ASP MET THR GLN GLY LEU GLY TRP GLU ALA TYR ASP TRP SEQRES 22 A 357 PRO ILE SER LEU LYS ARG LEU GLN ALA GLY ASN SER THR SEQRES 23 A 357 PRO MET ALA LEU GLN PRO HIS ARG ILE ALA ARG LEU PRO SEQRES 24 A 357 ALA PRO GLN ALA LEU GLU GLY GLN ARG LEU LEU ASN LYS SEQRES 25 A 357 THR GLY SER THR ASN GLY PHE GLY ALA TYR VAL ALA PHE SEQRES 26 A 357 VAL PRO GLY ARG ASP LEU GLY LEU VAL ILE LEU ALA ASN SEQRES 27 A 357 ARG ASN TYR PRO ASN ALA GLU ARG VAL LYS ILE ALA TYR SEQRES 28 A 357 ALA ILE LEU SER GLY LEU SEQRES 1 B 357 MET ASP ARG LEU LYS ALA LEU VAL ASP ALA ALA VAL GLN SEQRES 2 B 357 PRO VAL MET LYS ALA ASN ASP ILE PRO GLY LEU ALA VAL SEQRES 3 B 357 ALA ILE SER LEU LYS GLY GLU PRO HIS TYR PHE SER TYR SEQRES 4 B 357 GLY LEU ALA SER LYS GLU ASP GLY ARG ARG VAL THR PRO SEQRES 5 B 357 GLU THR LEU PHE GLU ILE GLY SER VAL SER LYS THR PHE SEQRES 6 B 357 THR ALA THR LEU ALA GLY TYR ALA LEU THR GLN ASP LYS SEQRES 7 B 357 MET ARG LEU ASP ASP ARG ALA SER GLN HIS TRP PRO ALA SEQRES 8 B 357 LEU GLN GLY SER ARG PHE ASP GLY ILE SER LEU LEU ASP SEQRES 9 B 357 LEU ALA THR TYR THR ALA GLY GLY LEU PRO LEU GLN PHE SEQRES 10 B 357 PRO ASP SER VAL GLN LYS ASP GLN ALA GLN ILE ARG ASP SEQRES 11 B 357 TYR TYR ARG GLN TRP GLN PRO THR TYR ALA PRO GLY SER SEQRES 12 B 357 GLN ARG LEU TYR SER ASN PRO SER ILE GLY LEU PHE GLY SEQRES 13 B 357 TYR LEU ALA ALA ARG SER LEU GLY GLN PRO PHE GLU ARG SEQRES 14 B 357 LEU MET GLU GLN GLN VAL PHE PRO ALA LEU GLY LEU GLU SEQRES 15 B 357 GLN THR HIS LEU ASP VAL PRO GLU ALA ALA LEU ALA GLN SEQRES 16 B 357 TYR ALA GLN GLY TYR GLY LYS ASP ASP ARG PRO LEU ARG SEQRES 17 B 357 VAL GLY PRO GLY PRO LEU ASP ALA GLU GLY TYR GLY VAL SEQRES 18 B 357 LYS THR SER ALA ALA ASP LEU LEU ARG PHE VAL ASP ALA SEQRES 19 B 357 ASN LEU HIS PRO GLU ARG LEU ASP ARG PRO TRP ALA GLN SEQRES 20 B 357 ALA LEU ASP ALA THR HIS ARG GLY TYR TYR LYS VAL GLY SEQRES 21 B 357 ASP MET THR GLN GLY LEU GLY TRP GLU ALA TYR ASP TRP SEQRES 22 B 357 PRO ILE SER LEU LYS ARG LEU GLN ALA GLY ASN SER THR SEQRES 23 B 357 PRO MET ALA LEU GLN PRO HIS ARG ILE ALA ARG LEU PRO SEQRES 24 B 357 ALA PRO GLN ALA LEU GLU GLY GLN ARG LEU LEU ASN LYS SEQRES 25 B 357 THR GLY SER THR ASN GLY PHE GLY ALA TYR VAL ALA PHE SEQRES 26 B 357 VAL PRO GLY ARG ASP LEU GLY LEU VAL ILE LEU ALA ASN SEQRES 27 B 357 ARG ASN TYR PRO ASN ALA GLU ARG VAL LYS ILE ALA TYR SEQRES 28 B 357 ALA ILE LEU SER GLY LEU HET OP0 A 401 21 HET NI A 402 1 HET NI A 403 1 HET OP0 B 401 21 HETNAM OP0 (2S,5R)-N-(2-AMINOETHOXY)-1-FORMYL-5-[(SULFOOXY) HETNAM 2 OP0 AMINO]PIPERIDINE-2-CARBOXAMIDE HETNAM NI NICKEL (II) ION FORMUL 3 OP0 2(C9 H18 N4 O7 S) FORMUL 4 NI 2(NI 2+) FORMUL 7 HOH *242(H2 O) HELIX 1 AA1 MET A 31 ASN A 49 1 19 HELIX 2 AA2 VAL A 91 GLN A 106 1 16 HELIX 3 AA3 ARG A 114 GLN A 123 5 10 HELIX 4 AA4 SER A 125 GLY A 129 5 5 HELIX 5 AA5 SER A 131 THR A 137 1 7 HELIX 6 AA6 ASP A 154 TRP A 165 1 12 HELIX 7 AA7 SER A 178 LEU A 193 1 16 HELIX 8 AA8 PRO A 196 GLN A 204 1 9 HELIX 9 AA9 GLN A 204 LEU A 209 1 6 HELIX 10 AB1 PRO A 219 TYR A 226 5 8 HELIX 11 AB2 LEU A 244 GLY A 250 1 7 HELIX 12 AB3 ALA A 255 HIS A 267 1 13 HELIX 13 AB4 PRO A 268 LEU A 271 5 4 HELIX 14 AB5 ASP A 272 THR A 282 1 11 HELIX 15 AB6 SER A 306 ASN A 314 1 9 HELIX 16 AB7 SER A 315 GLN A 321 1 7 HELIX 17 AB8 PRO A 357 ARG A 359 5 3 HELIX 18 AB9 PRO A 372 GLY A 386 1 15 HELIX 19 AC1 ASP B 32 ASN B 49 1 18 HELIX 20 AC2 VAL B 91 GLN B 106 1 16 HELIX 21 AC3 ARG B 114 GLN B 123 5 10 HELIX 22 AC4 SER B 125 GLY B 129 5 5 HELIX 23 AC5 SER B 131 THR B 137 1 7 HELIX 24 AC6 ASP B 154 TRP B 165 1 12 HELIX 25 AC7 SER B 178 LEU B 193 1 16 HELIX 26 AC8 PRO B 196 GLN B 204 1 9 HELIX 27 AC9 GLN B 204 LEU B 209 1 6 HELIX 28 AD1 PRO B 219 TYR B 226 5 8 HELIX 29 AD2 LEU B 244 TYR B 249 1 6 HELIX 30 AD3 ALA B 255 HIS B 267 1 13 HELIX 31 AD4 PRO B 268 LEU B 271 5 4 HELIX 32 AD5 ASP B 272 THR B 282 1 11 HELIX 33 AD6 SER B 306 ASN B 314 1 9 HELIX 34 AD7 SER B 315 GLN B 321 1 7 HELIX 35 AD8 PRO B 357 ARG B 359 5 3 HELIX 36 AD9 PRO B 372 GLY B 386 1 15 SHEET 1 AA1 9 GLU A 63 GLY A 70 0 SHEET 2 AA1 9 GLY A 53 LEU A 60 -1 N VAL A 56 O PHE A 67 SHEET 3 AA1 9 LEU A 361 ALA A 367 -1 O LEU A 366 N ALA A 55 SHEET 4 AA1 9 PHE A 349 VAL A 356 -1 N ALA A 354 O LEU A 363 SHEET 5 AA1 9 ARG A 338 THR A 346 -1 N GLY A 344 O ALA A 351 SHEET 6 AA1 9 GLU A 299 ASP A 302 -1 N TYR A 301 O LEU A 339 SHEET 7 AA1 9 MET A 292 GLN A 294 -1 N THR A 293 O ALA A 300 SHEET 8 AA1 9 ARG A 284 VAL A 289 -1 N TYR A 287 O GLN A 294 SHEET 9 AA1 9 ALA A 326 ALA A 333 -1 O GLN A 332 N GLY A 285 SHEET 1 AA2 3 LEU A 85 GLU A 87 0 SHEET 2 AA2 3 LYS A 252 SER A 254 -1 O THR A 253 N PHE A 86 SHEET 3 AA2 3 THR A 214 HIS A 215 -1 N HIS A 215 O LYS A 252 SHEET 1 AA3 2 GLN A 174 ARG A 175 0 SHEET 2 AA3 2 HIS A 323 ARG A 324 -1 O HIS A 323 N ARG A 175 SHEET 1 AA4 2 GLY A 229 TYR A 230 0 SHEET 2 AA4 2 PRO A 236 LEU A 237 -1 O LEU A 237 N GLY A 229 SHEET 1 AA5 9 GLU B 63 GLY B 70 0 SHEET 2 AA5 9 GLY B 53 LEU B 60 -1 N VAL B 56 O PHE B 67 SHEET 3 AA5 9 LEU B 361 ALA B 367 -1 O GLY B 362 N SER B 59 SHEET 4 AA5 9 GLY B 350 VAL B 356 -1 N ALA B 354 O LEU B 363 SHEET 5 AA5 9 ARG B 338 SER B 345 -1 N GLY B 344 O ALA B 351 SHEET 6 AA5 9 GLU B 299 ASP B 302 -1 N TYR B 301 O LEU B 339 SHEET 7 AA5 9 MET B 292 GLN B 294 -1 N THR B 293 O ALA B 300 SHEET 8 AA5 9 ARG B 284 VAL B 289 -1 N TYR B 287 O GLN B 294 SHEET 9 AA5 9 ALA B 326 ALA B 333 -1 O GLN B 332 N GLY B 285 SHEET 1 AA6 2 LEU B 85 GLU B 87 0 SHEET 2 AA6 2 LYS B 252 SER B 254 -1 O THR B 253 N PHE B 86 SHEET 1 AA7 2 GLN B 174 ARG B 175 0 SHEET 2 AA7 2 HIS B 323 ARG B 324 -1 O HIS B 323 N ARG B 175 SHEET 1 AA8 2 GLY B 229 TYR B 230 0 SHEET 2 AA8 2 PRO B 236 LEU B 237 -1 O LEU B 237 N GLY B 229 LINK OG SER A 90 C1 OP0 A 401 1555 1555 1.36 LINK OG SER B 90 C1 OP0 B 401 1555 1555 1.36 LINK OD2 ASP A 149 NI NI A 403 1555 1555 2.76 LINK OD2 ASP A 360 NI NI A 402 1555 1555 2.32 LINK NI NI A 403 NE2 HIS B 267 1555 1555 2.56 LINK NI NI A 403 OD1 ASP B 360 1555 1555 2.65 CISPEP 1 TRP A 303 PRO A 304 0 6.94 CISPEP 2 TRP B 303 PRO B 304 0 4.07 SITE 1 AC1 14 SER A 90 GLN A 146 TYR A 177 ASN A 179 SITE 2 AC1 14 TYR A 249 LYS A 342 THR A 343 GLY A 344 SITE 3 AC1 14 SER A 345 ASN A 373 HOH A 572 HOH A 605 SITE 4 AC1 14 HOH A 620 HOH A 621 SITE 1 AC2 2 HIS A 267 ASP A 360 SITE 1 AC3 3 ASP A 149 HIS B 267 ASP B 360 SITE 1 AC4 18 ILE B 88 GLY B 89 VAL B 91 SER B 92 SITE 2 AC4 18 LYS B 93 GLN B 146 TYR B 177 ASN B 179 SITE 3 AC4 18 GLY B 248 TYR B 249 LYS B 342 THR B 343 SITE 4 AC4 18 GLY B 344 SER B 345 ASN B 373 HOH B 668 SITE 5 AC4 18 HOH B 713 HOH B 714 CRYST1 74.027 54.781 75.667 90.00 90.80 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013509 0.000000 0.000188 0.00000 SCALE2 0.000000 0.018255 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013217 0.00000